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ABSTRACT 
Objective: The increased information provided by modern imaging has led to its more extensive use.  Our aim was to 
develop evidence based recommendations for the use of imaging in the clinical management of the commonest 
arthropathy, osteoarthritis (OA). 
Methods: A task force (including rheumatologists, radiologists, methodologists, primary care doctors and patients) 
from 9 countries defined 10 questions on the role of imaging in OA to support a systematic literature review (SLR). 
Joints of interest were the knee, hip, hand and foot; imaging modalities included conventional radiography (CR), MRI, 
ultrasonography, CT and nuclear medicine. PubMed and EMBASE were searched. The evidence was presented to the 
task force who subsequently developed the recommendations. The strength of agreement for each recommendation 
was assessed. 
Results: 17,011 references were identified from which 390 studies were included in the SLR. Seven recommendations 
were produced, covering: the lack of need for diagnostic imaging in patients with typical symptoms; the role of 
imaging in differential diagnosis; the lack of benefit in monitoring when no therapeutic modification is related, though 
consideration is required when unexpected clinical deterioration occurs; CR as the first choice imaging modality; 
consideration of how to correctly acquire images; and the role of imaging in guiding local injections. 
Recommendations for future research were also developed based on gaps in evidence, such as the use of imaging in 
identifying therapeutic targets, and demonstrating the added value of imaging. 
Conclusions: These evidence-based recommendations and related research agenda provide the basis for sensible use 
of imaging in routine clinical assessment of people with OA.   
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INTRODUCTION 
 
Osteoarthritis (OA) is a major cause of pain and disability worldwide. Although conventional radiography (CR) is the 
most commonly used technique to evaluate structural features of OA, significant advances have been made in the 
field of imaging over the last decade, allowing a more accurate evaluation of both bone and soft-tissue abnormalities. 
While newer modalities such as magnetic resonance imaging (MRI) and ultrasound have increased the understanding 
of the multiple pathologies contributing to the OA phenotype, it is not clear how they should be used in routine care.   
The role of imaging in clinical practice for OA diagnosis, management and follow-up has not been clearly defined. 
Despite this limitation, the increased availability of modern imaging has expanded its use, with possible excesses [1] 
leading to increased costs. A European League Against Rheumatism (EULAR) task force was therefore created to 
develop evidence-based recommendations on the use of imaging in the management of symptomatic, peripheral joint 
OA, for clinicians who treat OA in their clinical practice.  
 
METHODS 
 
A group selected from a range of expertise (rheumatologists, radiologists, primary care physicians, methodologists 
and patients) and representing 9 countries were included in the task force. During the first meeting, the focus of the 
recommendations (symptomatic OA affecting the knee, hip, hand or foot) was clarified. Clinically relevant questions 
on the application of imaging in OA were proposed and 9 research questions were selected by consensus to guide a 
detailed systematic literature review (SLR).  Two questions that covered the same area were subsequently combined. 
The areas of diagnosis, prognosis, follow-up and treatment were covered. The questions were rephrased according to 
the PICO (population, intervention, comparison, outcome) (see supplementary fileS1 Research Questions).   
A SLR was performed by one of the authors (GS), with checking of all extractions by one of 3 other authors 
experienced in SLRs. The search strategies were based on both MeSh (Medical Subject Headings) terms and free text. 
The searches were performed separately for each joint (see supplementary file S2 Search Strategies). The titles and 
abstracts of the references that were retrieved were screened by the same author according to pre-defined inclusion 
and exclusion criteria, based on the PICO for each question, and potentially relevant articles were evaluated in their 
full text. Studies in English including adults (A?18) with symptomatic OA of the knee, hip, hand and foot were eligible 
for inclusion. Imaging modalities included were CR, MRI, ultrasonography (US), computed tomography (CT) and 
nuclear medicine techniques (scintigraphy, positron emission tomography, PET). Randomized controlled trials, 
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systematic reviews and meta-analyses, controlled clinical trials, case-control studies, cross-sectional studies and 
cohort studies were eligible for inclusion. Studies had to examine the role of imaging in the following: in making a 
diagnosis of OA; in detecting OA elementary lesions; for differential diagnosis; in the management of OA; in predicting 
outcome and therapeutic response; for follow-up of disease course; to guide treatment. The same articles could be 
included in more than one search. Due to the variety of joint sites and imaging and the expectation of a strong degree 
of heterogeneity across studies, meta-analyses were not pre-specified before study selection and extraction. The 
methodological quality of the included studies was not assessed by quality scores, but some aspects were considered  
for all studies, together with design-specific indicators . For all studies, study design, sample size, setting sampling 
were considered. For RCTs allocation concealment, drop-out rate as well as the presence of funding, for diagnostic 
studies the adequacy of the reference standard, for cohort studies the presence of adjustment for confounders were 
also evaluated. Each aspect was evaluated separately as leading to high, low or unclear risk of bias. 
During the second ŵĞĞƚŝŶŐƚŚĞƌĞƐƵůƚƐŽĨƚŚĞůŝƚĞƌĂƚƵƌĞƌĞǀŝĞǁǁĞƌĞƉƌĞƐĞŶƚĞĚĂŶĚƚŚĞĞǆƉĞƌƚƐĚĞǀĞůŽƉĞĚ ?ŽǀĞƌ-
ĂƌĐŚŝŶŐ ?ƐƚĂƚĞŵĞŶƚƐ ?ďĂĐŬŐƌŽƵŶĚƐƚĂƚĞŵĞŶƚƐƚŽƉreface the recommendations) and drafted 7 recommendations 
through a process of discussion and consensus. The number of recommendations emerged through the discussion 
after the presentation of the literature, when evidence from the literature was limited the recommendations were 
based on the opinion of the experts. To explore the presence of additional evidence concerning two 
recommendations, two more research questions on 1) the different performance of various radiographic views in 
detecting OA features and 2) the accuracy of imaging guided compared to blind joint injections were added to the 
original 8, with two additional literature searches (See supplementary file S1, research questions and S2, search 
strategies). After evaluation of these results, the Task Force confirmed the final wording of the recommendations and  
scored the perceived level of agreement (LOA) for each statement using a 0-10 numeric rating scale (0=fully disagree; 
10=fully agree), reflecting both literature evidence and expert opinion. Recommendations for further research were 
then developed based on gaps in the SLRs. 
 
RESULTS 
 
The searches in the electronic databases (PubMed, Embase) were performed up to the end of January 2015 for the 
main searches and December 2015 for the additional searches. The initial search resulted in 6858 records, (615 
duplicates). Of the remaining 6243 articles, 4926 were excluded based on the title and abstracts, leaving 1317 articles 
for detailed review. All full text articles were retrieved, 986 articles were excluded after reviewing the full text leaving 
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331 articles for inclusion (supplementary file S3, online only). The hand search of the references of the included 
studies identified 33 additional articles, leading to a total of 364 studies finally analyzed.  Articles that were relevant to 
more than one research question were used for each question as appropriate. The number of articles included for 
each site and imaging are shown in figure S4, available online only. The complete results of the SLR with references 
are reported in the supplementary file S5. 
The additional search on the comparison of different radiographic views resulted in 4774 articles (225 duplicates). Of 
the remaining 4549, 4496 were excluded based on the title and abstracts, leaving 53 articles for detailed review. 
Twenty-three articles were excluded after reviewing the full text, leaving 30 articles for inclusion. The hand search 
identified 1 additional article for inclusion, leading to a total of 31 articles finally included (supplementary file S6, 
online only).  
The additional search on the added value of imaging to guide intra-articular procedures resulted in 5379 articles, (834 
duplicates). Of the remaining 4545, 4520 were excluded based on the title and abstracts, leaving 25 articles for 
detailed review. Nineteen articles were excluded after reviewing the full text leaving 6 articles for inclusion. The hand 
search identified 2 additional articles for inclusion, leading to a total of 8 articles finally included (supplementary file 
S7, online only). The complete results of the additional searches with references are reported in the supplementary 
file S8. 
 
Recommendations 
 
Table 1 summarizes the 7 recommendations with their corresponding level of evidence and LOA. Each 
recommendation is presented in detail below. 
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Table 1. Recommendations, levels of evidence and level of agreement (LOA) 
 
Recommendation Level of evidence LOA, mean  (95% CI) 
1. Imaging is not required to make the diagnosis in patients with 
typical* presentation of OA.  
*typical features include: usage-related pain, short duration 
morning stiffness, age>40, symptoms affecting one or a few 
joints. 
III-IV 8.7 (7.9, 9.4) 
2. In atypical presentations imaging is recommended to help 
confirm the diagnosis of OA and/or make alternative or 
additional diagnoses. 
IV 9.6 (9.1, 10) 
3. Routine imaging in OA follow-up is not recommended. 
However, imaging is recommended if there is unexpected 
rapid progression of symptoms or change in clinical 
characteristics to determine if this relates to OA severity or 
an additional diagnosis. 
III-IV 8.8 (7.9, 9.7) 
4. If imaging is needed, conventional (plain) radiography should 
be used before other modalities. To make additional 
diagnoses, soft tissues are best imaged by US or MRI and 
bone by CT or MRI. 
III-IV 8.7 (7.9, 9.6) 
5. Consideration of radiographic views is important for 
optimizing detection of OA features; in particular for the 
knee, weight-bearing and patellofemoral views are 
recommended. 
III 9.4 (8.7, 9.9) 
6. According to current evidence, imaging features do not 
predict non-surgical treatment response and imaging cannot 
be recommended for this purpose. 
II-III 8.7 (7.5, 9.7) 
7. The accuracy of intra-articular injection depends on the joint 
and on the skills of the practitioner and imaging may improve 
accuracy. Imaging is particularly recommended for joints that 
are difficult to access due to factors including site (e.g. hip), 
degree of deformity and obesity. 
III-IV 9.4 (8.9, 9.9) 
 
Categories of evidence: Ia, evidence for meta-analysis of randomized controlled trials; Ib, evidence from at least one randomized controlled trial; IIa, evidence from at least one 
controlled study without randomization; IIb, evidence from at least one other type of quasi-experimental study; III, evidence from non-experimental descriptive studies, such as 
comparative studies, correlation studies and case ?control studies; IV, evidence from expert committee reports or opinions or clinical experience of respected authorities, or both 
LOA: 0-10 numerical rating scale 
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Overarching statements 
 
1. These recommendations pertain only to symptomatic OA. 
2. Imaging abnormalities of OA are commonly seen especially with increasing age. 
3. Joint symptoms are also common and increase with age. Symptoms are not always causally related to 
imaging abnormalities. 
4. Full history and examination is always required before considering the need for investigations, including 
imaging. 
5. Modern imaging modalities provide the capability to detect a wide range of soft tissue, bony and cartilage 
pathology in OA. However, the increased information provided has not yet had any influence on clinical 
decision making with respect to management, 
 
Making a diagnosis of OA 
 
Recommendation 1: Imaging is not required to make the diagnosis in patients with typical* presentation of OA.  
*typical features include: usage-related pain, short duration morning stiffness, age>40, symptoms affecting one or a 
few joints.  Level of evidence: III-IV. Level of agreement (95%CI): 8.7 (7.9, 9.4) 
 
Although many studies applied imaging for diagnostic purposes, there was a lack of studies in which imaging was 
applied in addition to clinical findings to evaluate its additional impact on the certainty of diagnosis, which was a 
predefined criterion for inclusion.  
A single study examined the added value of US of hand and feet over clinical findings in a cohort of patients with 
suspected or confirmed arthritis. When US was added to clinical findings, the diagnostic confidence in differentiating 
OA from inflammatory arthritis significantly increased. [2] Due to the absence of strong evidence supporting the use 
of different imaging modalities at different anatomical sites, the systematic use of imaging in the diagnostic process 
was not recommended in cases with typical clinical presentation. However, based on the joint site and clinical 
presentation, imaging might be considered when diagnoses other than OA are suspected. This aspect has been taken 
into account in recommendation 2. 
 
Recommendation 2: In atypical presentations imaging is recommended to help confirm the diagnosis of OA and/or 
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make alternative or additional diagnoses. Level of evidence: IV. Level of agreement (95%CI): 9.6 (9.1, 10) 
 
Studies were eligible for inclusion if they investigated the added value of imaging for differential diagnosis over clinical 
evaluation. Among studies evaluating the application of imaging for differential diagnosis, no study evaluated the 
impact of the addition of imaging above clinical findings. The possible application if imaging in atypical clinical 
scenarios was however recognized by the experts, which included this point in the recommendation. 
 
Monitoring disease 
Recommendation 3: Routine imaging in OA follow-up is not recommended. However, imaging is recommended if 
there is unexpected rapid progression of symptoms or change in clinical characteristics to determine if this relates 
to OA severity or an additional diagnosis. Level of evidence: III-IV. Level of agreement (mean, 95%CI): 8.8 (7.9, 9.7) 
 
A specific question addressed the use of imaging for the follow-up. The 117 studies (mostly cohort studies) retrieved 
covered all joint sites except the foot and all imaging modalities except CT (Figure S9). Most of the 83 included studies 
focused on sensitivity to change. [3-86] The remaining studies investigated  the trajectories of changes of elementary 
lesions detected by imaging when following OA natural history or described the parallel changes between different 
abnormalities detected by different imaging modalities. [87-105] Only a minority of studies examined the correlation 
between the change in imaging features and symptoms or relevant clinical outcomes (Table 2) and only 4 US studies 
evaluated the change of imaging after treatment  (Supplementary file S10). [106-115]  
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Table 2. Studies correlating changes in imaging findings with symptoms, function or clinical outcome 
 
Study N Site  Study design Imaging  Outcome 
Fukui 2010 68 Knee  Cohort CR Correlation between radiographic 
progression and pain and function 
scores 
Progressors had more pain and disability compared to non  
progressors 
Eckstein 2014 189 Knee Case-control MRI Cartilage loss in patients undergoing 
TKA vs controls 
OR (95%CI) for cartilage loss in patients undergoing TKA vs 
controls: 1.36 (1.08,1.70) 
Kornaat 2007 182 Knee Cohort MRI Change in BMLs/change in WOMAC 
pain and function  
No significant differences in WOMAC pain and function 
depending on the changes of BMLs 
Phan 2006  34 Knee Cohort MRI Cartilage and BMLs/WOMAC  No significant correlation between cartilage loss, BMLs and 
WOMAC changes 
Zhang Y 2011 651 Knee Cohort MRI Change in pain status according to 
change in BMLs and 
effusion/synovitis score 
Changes in BMLs and synovitis severity (worsening or 
improving) significantly related to the risk of frequent knee 
pain (p 0.006 for worsening BMLs and p 0.045 for 
improving BMLs. No significant correlation with changes in 
effusion severity. 
Haugen 2013 190 Hand Cohort CR Radiographic progression/incident 
tenderness 
joints with progression had higher Odds for tenderness, 
joints with incident KL 3 or 4 had higher Odds for 
tenderness 
N: number of participants; CR: conventional radiography; MRI: magnetic resonance imaging; TKA: total knee arthroplasty; OR: Odds Ratio; 95% CI: 95% confidence interval; 
WOMAC Western Ontario MacMaster Universities Arthritis Index; BMLs: bone marrow lesions 
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Moreover, there were no studies comparing clinical follow-up with imaging follow-up, or strategies adding imaging to 
clinical management. 
The impact of imaging in the management of OA was also specifically addressed by the literature search. Three studies 
addressed this point. One RCT evaluating the impact of MRI in patients with knee pain assessed in a general practice 
setting showed that MRI led to an increase in therapeutic confidence but no significant changes in management. [116] 
A cross-sectional study in an orthopedic setting investigating the impact of CR over management decisions in knee OA 
showed that CR led to the change in the opinion in 166/400 cases.  [117] A similar study evaluating the impact of CR in 
the assignment of priority for surgery in hip OA, showed a relative risk (95% CI) of 1.98 (1.23, 3.19) for an earlier 
assignment in patients with more severe radiographic scores. [118] No studies evaluated the impact of imaging for the 
management of hand or foot OA and no studies specifically addressed the issue of non-surgical management. 
 
Recommendation 4: If imaging is needed, conventional (plain) radiography should be used before other modalities. 
To make additional diagnoses, soft tissues are best imaged by US or MRI and bone by CT or MRI. Level of evidence: 
III-IV. Level of agreement (95%CI): 8.7 (7.9, 9.6) 
 
The performance of imaging in the detection of OA elementary lesions was addressed by the SLR, and highlighted 
heterogeneity in the use of imaging modality, lesions considered and reference standard. In fact, physical examination 
was frequently taken into account as reference standard, while surgery was considered in a minority of studies. 
Supplementary file S11 summarizes the studies with surgery as the reference standard. [119-140] As expected, the 
use of CR was mainly to detect bone and indirectly cartilage loss, MRI was used for bone, cartilage and soft tissues, 
with a single study assessing US for the evaluation of cartilage. 
In general, CR was the imaging modality that was most frequently used for diagnostic, prognostic and follow-up 
purposes. However, no studies of the cost-effectiveness of each imaging modality or theirsequence were found. In the 
absence of appropriate literature, the experts decided to emphasize the role of the most easily available and less 
costly imaging modality, proposing as second level investigations techniques that, due to their characteristics, are 
more suitable for the detailed assessment of soft tissues (MRI and US) or bone (CT). 
 
Recommendation 5: Consideration of radiographic views is important for optimizing detection of OA features; in 
particular for the knee, weight-bearing and patellofemoral views are recommended. Level of evidence: III. Level of 
agreement (95%CI): 9.4 (8.7, 9.9) 
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This topic was addressed by an additional research question, evaluating the optimal combination of radiographic 
views in OA. Twenty-seven studies comparing different views for knee OA were included. In this context, all studies 
involving the tibiofemoral compartment considered weight-bearing views, both in extension and various degrees of 
flexion. [17, 127,147-159] Studies comparing fully extended and flexed views in general showed a moderate to good 
agreement between the two projections   and similar sensitivity and specificity in detecting cartilage damage, 
considering arthroscopic findings as reference. [121, 145, 146, 151, 152] The flexed views demonstrated superiority in 
detecting joint space narrowing, a greater sensitivity to change and reproducibility compared to extended views. [17, 
153,154,156, 158, 159] 
Concerning the assessment of the patellofemoral compartment, skyline views had a greater inter- and intra-reader 
reliability and sensitivity to change compared to lateral projections. [24, 146, 158, 159] With surgery as reference 
standard, the skyline view had greater sensitivity and specificity to detect cartilage damage at the patellofemoral joint. 
[160] 
There were 5 studies assessing the hip. Three studies compared weight-bearing and supine AP views of the pelvis, one 
of them showing greater average and maximal joint space width detected by the weight-bearing view, the remaining 
showing inconsistent results. [161-165] Two studies comparing pelvis, hip and oblique views projections in terms of 
reliability and sensitivity to change demonstrated similar reliability for views dedicated to the hip and views including 
all the pelvis, with comparable sensitivity to change. [166,167] No studies assessing the hand and the foot were found. 
 
Role in prognosis  
Recommendation 6: According to current evidence, imaging features do not predict non-surgical treatment 
response and imaging cannot be recommended for this purpose. Level of evidence: II-III. Level of agreement (95%CI): 
8.7 (7.5, 9.7) 
 
Two specific research questions addressed the role of imaging in prognosis, referring to both the prediction of the 
natural history and to the prediction of non-surgical treatment outcomes. A number of studies addressed the issue of 
the prognostic value of imaging as predictor of the natural history of OA (Figure S12), while only a minority of studies, 
evaluating all joint sites, investigated the role in predicting treatment response. Due to the heterogeneity in 
populations, interventions, treatment and study design, a meta-analysis was not possible. In addition, progression of 
some imaging pathologies may have limited clinical significance.  Tables 3 and 4 summarize the results of the 28 
13 
 
primary studies in which imaging was applied to predict treatment response. [170-193] Moreover, an existing SLR was 
available, without a quantitative synthesis. [194] The results on the prediction of response were mostly inconsistent 
across studies; for this reason the use of imaging for this purpose was not recommended. 
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Table 3. Summary of studies evaluating imaging in the prediction of response to treatment: systemic treatment 
Study N Site  Study design Imaging  Outcome 
Gudbergsen  2012 192 Knee  RCT CR MRI mJSW, alignment and MRI scores/pain 
reduction in response to very low energy 
diet or low energy diet 
Among all radiographic and MRI parameters, only effusion score 
was significantly related to a reduction in pain 
Gudbergsen 2011 30 Knee RCT CR MRI KLG and MRI score/change in WOMAC 
pain and function during weight 
reduction at 32 weeks 
No significant association between KLG and MRI score and 
WOMAC 
Hellio le Graverand 2013 1452 Knee  RCT CR KLG/structural progression in patients 
treated with cidunistat or placebo at 96 
weeks 
No significant difference between KLG2 and KLG3 in terms of 
progression of joint space narrowing in both cidunistat and 
placebo group 
Case  2003 82 Knee  RCT CR KLG and medial JSN/WOMAC response 
to diclofenac vs paracetamol at 12 
weeks 
Patients with KLG 1-2 and not 3-4 and JSN grade 0-1 compared to 
2 had a better response to diclofenac vs both placebo and 
paracetamol  
Sawitzke 2008 375 Knee RCT CR KLG/radiographic progression during 
treatment with glucosamine, chondroitin 
sulphate and celecoxib at 24 months 
OR for radiographic progression compared with the placebo 
group was <1 in patients with KLG 2 knees in all treatment groups, 
whereas it was>1 in patients with KLG 3 knees in all treatment 
groups 
Mazzuca 2010 379 Knee RCT CR Alignment/radiographic progression in 
doxycycline vs placebo at 30 months 
Varus knees exhibited a greater loss of JSW than non-varus knees 
in patients receiving doxycycline 
Knoop 2014 91 Knee Cohort  MRI  MRI/change in WOMAC function in 
response to exercise program at 12 
weeks 
The severity of the patellofemoral damage was significantly 
related to less improvement  
Wenham 2012 65 Hand RCT MRI MRI/response to prednisolone 5 mg at 
12 weeks 
The baseline number of joints with definite synovitis or effusion 
did not correlate with OARSI response 
Lequesne 2002 163 Hip RCT CR JSW/structural progression in patients 
treated with avocado soybean at 2 years 
In patients with smaller JSW treated with avocado soybean, the 
reduction of JSW was half than in the placebo group; no 
differences in patients with more JSW 
Rozendaal 2009 222 Hip RCT CR KLG/WOMAC pain and function, JSN in 
patients taking glucosamine at 2 years 
Significant better WOMAC function response in patients with KLG 
1 compared to KLG 2; no differences in WOMAC pain and JSN 
Hoeksma 2005 103 Hip RCT CR KLG/Harris Hip score and range of 
motion in response to manual therapy vs 
exercise 
Better response in terms of range of motion in lower compared to 
higher radiographic grades 
N: number of participants; RCT: randomized controlled trial;  MRI: magnetic resonance imaging;  CR: conventional radiography; BML: bone marrow lesions; mJSW: minimal joint 
space width; JSN: joint space narrowing; JSW: joint space width; WOMAC: Western Ontario Mc Master Universities Osteoarthritis index; KLG: Kellgren and Lawrence grade; OARSI: 
osteoarthritis research society international 
 
15 
 
Table 4. Summary of studies evaluating imaging in the prediction of response to treatment: intra-articular treatment 
Study N Site  Study design Imaging  Outcome 
Barrett 1990 248 Knee cohort CR Radiographic severity/response to 
intraarticular HA at 6 months 
Patients with less severe radiographic grade had a better 
response in terms of pain at rest, at walking and at night 
Gaffney 1995 84 Knee  RCT CR OA severity 0-3/response to 
intraarticular trimacinolone vs placebo 
at 3 weeks 
No  association between improvement in VAS pain and 
radiographic score 
Toh 2002 60 Knee cohort CR Alignment, sclerosis, cysts, osteophytes, 
JSN/WOMAC response to intraarticular 
HA at 12 weeks 
Patients with lateral and medial JSN had less WOMAC response 
compared to patients without 
Pendleton 2008 86 Knee cohort US US/WOMAC response to intraarticular 
methylprednisolone 
Higher baseline US scores: significant improvements in  all  
WOMAC subscales at 1 and 6 weeks 
Chao 2010 67 Knee RCT US US inflammation/WOMAC response to 
triamcinolone at 12 weeks 
statistically significant improvement in pain subscales among 
without inflammatory abnormalities at US patients compared to 
the remaining patients 
Anandacoomarasamy 
2008 
32 Knee Cohort  MRI  Cartilage volume/response to 
intraarticular HA at 6 months 
no correlation between baseline MRI measures and clinical 
response 
Drakonaki 2011 51 Foot  Cohort  CR US Positive therapeutic response (i.a. 
methylprednisolone) at 12 months 
No differences in terms of response in patients showing 
degenerative changes only on US and those showing changes in 
both US and CR 
Han 2014 40 Foot  Cohort  CR Response to intraarticular HA (VAS pain) 
at 12 months 
Patients with early radiographic stage had a better response 
compared to those with advanced radiographic stage at 3 and 6 
months, but not at 12 months 
Sun 2011 46 Foot Cohort CR KLG 2 and 3/AOS, AOFAS scores in 
response to intraarticular HA 
no significant difference in the AOS, AOFAS, or clinical balance 
test scores between KLG 2 and 3 at any time point 
Mallinson 2013 31 Hand  Cohort CR US CR and US/ response to intraarticular 
triamcinolone at 6 weeks 
No significant association between treatment response and grade 
for osteophytes, joint-space narrowing and capsule thickness 
Atchia 2011 77 Hip RCT US Synovitis/response to i.a. 
methylprednisolone at 6 weeks 
The presence of synovitis significantly predicted the response 
Rennesson- Rey 2008 55 Hip Cohort CR US Effusion and KLG/OARSI response to HA 
at 6 months 
Patients with KLG 1-2 had a better 1 months response compared 
to grades 3-4; non differences at 3 and 6 months, no differences 
in patients with or without effusion 
Deshmukh 2011 220 Hip Cohort CR KLG/pain relief after methylprednisolone 
injections at 2 weeks 
Patients with KLG 3-4 had more frequently delayed relief 
compared to KLG 2 
Robinson 2007 120 Hip Cohort CR US US osteophytes and capsular thickening, 
KLG/WOMAC response to i.a. CS at 12 
weeks 
no baseline US or radiographic variable predictive of the outcome 
N: number of participants; RCT: randomized controlled trial; MRI: magnetic resonance imaging;  CR: conventional radiography; US: ultrasonography;  VAS: visual analogue scale; 
HA: hyaluronic acid;  JSN: joint space narrowing; WOMAC: Western Ontario Mc Master Universities Osteoarthritis index; KLG: Kellgren and Lawrence grade; OA: osteoarthritis; 
AOFAS Australian Orthopedic Foot and ankle society; OARSI: osteoarthritis research society international; CS: corticosteroids; i.a.: intra-articular 
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Treatment (imaging-guided procedures) 
Recommendation 7: The accuracy of intra-articular injection depends on the joint and on the skills of the 
practitioner and imaging may improve accuracy. Imaging is particularly recommended for joints that are difficult to 
access due to factors including site (e.g. hip), degree of deformity and obesity. Level of evidence: III-IV. Level of 
agreement (95%CI): 9.4 (8.9, 9.9) 
 
A search addressing the impact of imaging to guide intra-articular injections was run specifically for OA in the 
beginning. Including only studies comparing imaging-guided to blind procedures, 4 primary studies were found for the 
knee and one for the hand, and a qualitative systematic literature review for the knee (Table 5).  The added value of 
US was addressed by 4 studies, while fluoroscopic guidance was tested in a single study. [195-199]  
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Table 5. Studies comparing imaging-guided to blind injections in OA 
Study N Site  Study design Imaging  Outcome 
Bum Park 2012 99 Knee RCT US Accuracy of HA injection vs blind 
injection 
OR (95%CI) for an accurate injection with US compared to 
blind: 4.68 (0.94,23.30) 
Im 2006 99 Knee RCT US Accuracy of HA injection vs blind 
injection 
Accurate injections: 95.5% (US-guided) vs 77.2% (blind); 
p=0.01 
Jang 2013 126 Knee RCT US Accuracy of US guided in plain 
injection, US guided out of plane 
injections and  blind injection of 
triamcinolone exhacetonide 
Accuracy:  US guided in plain 95.1%; US guided out of plain 
97.7%;  Blind 78% 
P<0.05 blind vs US guided injections 
Sibbitt  2011 92 Knee RCT US US guided vs blind triamcinolone in 
terms of pain relief, pain related to 
the injection, reinjection rate and 
cost 
Significant decrease in pain only in patients treated with US 
guided injection; US guided procedure was related to lower 
pain and reinjection rate, but higher costs 
Karalezli 2007 16 Hand  Cohort CR Fluoroscopy-guided vs blind 
injections of HA in the trapezio-
metacarpal joint in terms of pain 
related to the injection 
VAS pain related to the procedure: Fluoroscopic guide:  4.1 
(range 3 ?6), anatomic guide 5.6 (range 3 ?7);  p<0.005 
No significant difference in terms of safety 
N: number of participants; RCT: randomized controlled trial; US: ultrasonography; CR: conventional radiography; HA: hyaluronic acid; OR: Odds Ratio; VAS: visual analogue scale. 
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In order to retrieve further information on this topic, an additional search was performed (supplementary file S1 for 
search strategies), including studies comparing blind to guided injections in OA and also in other conditions. This 
search found 8 studies, of which 3 were already included in the previous results (Supplementary file S13). [200-204] 
Most of the studies were focused on the knee, with some studies on the hand and the foot, while no studies were 
found for the hip. All the additional studies investigated the impact of US. Accuracy was found to be better in imaging 
guided compared to blind procedures, however the results on the clinical outcomes of the injection were less 
consistent across studies. For this reasons the systematic use of imaging to drive injections was not recommended, 
leaving this tool to drive injection in specific situations, identified by the experts. Although the imaging modality is not 
specified in the recommendation, there is published evidence for the use of US, and imaging allows for real time 
evaluation of injection placement. 
 
Future research agenda 
The most important topics to drive future research were selected by the Task Force based on the (often considerable) 
gaps in the evidence and the needs arising from clinical practice (Table 6). 
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Table 6: Future Research Agenda 
 
1 There is a need for methodologically robust studies to explore the added value of imaging (any modality) 
to clinical diagnosis or differential diagnosis.  
2 What is the cost-effectiveness of imaging in OA clinical practice? 
3 Is imaging able to help in identification of subgroups/phenotypes that may have different trajectories and 
enable targeted treatment based on these subgroups? 
4 There is a need to understand if using imaging to measure response to therapy is of clinical benefit. This 
may require evaluation of novel imaging technologies that are able to sensitively detect change in 
relevant joint structures. 
5 Quality studies are required to explore imaging (any modality) features that predict response to specific 
therapies. 
6 There is a need for more research concerning the benefits of imaging in less commonly studied OA sites 
such as the foot and shoulder. 
7 Specifically for hip OA, what is the added value of weight-bearing  vs non weight-bearing X-rays? 
8 What are the benefits of imaging-guidance in improving the efficacy of treatments? 
 
 
 
DISCUSSION 
 
Although a number of recommendations have been made on how to use imaging in OA clinical trials, these are the 
first recommendations on the use of imaging in OA in clinical practice. The development of the recommendations 
started from questions of clinical relevance selected by a task force of experts, with the aim to focus on topics of 
interest for clinical practice rather than research. The literature review identified a large number of studies, covering 
all the joint sites under examination. Although conventional radiography was still the most frequently applied 
technique, a substantial number of studies focused on modern imaging, MRI and US in particular.  
However, despite the amount of data available in the literature, only a small part of this information was relevant for 
clinical practice. For this reason, many areas needing further investigation were identified. In particular, there was a 
lack of strategic studies investigating the additional value of imaging over clinical findings in making a diagnosis of OA, 
in the management and the follow-up of the disease, and inconsistent results dealing with the prediction of the 
outcome of non-pharmacological treatments. The absence of good study information in these areas did not enable 
the Task Force to recommend systematic imaging in all these areas. A research agenda was therefore generated in 
order to address these topics in the future research. 
In conclusion, 7 recommendations covering different areas in the routine management of OA were developed. These 
are based on both available scientific evidence and expert opinion to provide a valuable and sensible guide for the use 
of imaging in clinical practice.
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